Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

    • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 244 to 293 of 3228 in total 
    Value Type: Ranked
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    
\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
244\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GSTO2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ba127l20.1 (novel glutathione-s-transferase). [source:sptrembl;acc:q9h4y5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.357\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
254.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11785\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
245\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNRPD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d3 (snrnp core protein d3) (sm-d3). [source:swissprot;acc:p43331]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.333\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11751\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
246\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF4G3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4 gamma, 3. [source:refseq;acc:nm\_003760]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.363\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11748\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
247\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna-binding protein. [source:refseq;acc:nm\_019027]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
237.302\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
212.41\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11719\vspace{3pt}}}\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
248\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
apobec-1 complementation factor isoform 1; apobec-1 stimulating protein; apo-b rna editing protein. [source:refseq;acc:nm\_014576]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
249\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SYNCRIP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ns1-associated protein 1. [source:refseq;acc:nm\_006372]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HNRNPR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein r (hnrnp r). [source:swissprot;acc:o43390]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
251\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC15A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
oligopeptide transporter, small intestine isoform (peptide transporter 1) (intestinal h+/peptide cotransporter) (solute carrier family 15, member 1). [source:swissprot;acc:p46059]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
186.172\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
166.661\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11707\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
252\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF4G1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4 gamma (eif-4-gamma) (eif- 4g) (eif4g) (p220). [source:swissprot;acc:q04637]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.292\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.457\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11689\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MXD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mad protein (max dimerizer). [source:swissprot;acc:q05195]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.333\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11583\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STT3B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
source of immunodominant mhc-associated peptides; homolog of yeast stt3 gene. [source:refseq;acc:nm\_178862]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
200.691\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
179.88\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11569\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
255\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STT3A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
oligosaccharyl transferase stt3 subunit homolog (b5) (integral membrane protein 1) (tmc). [source:swissprot;acc:p46977]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
256\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MXI1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
max interacting protein 1 (mxi1 protein). [source:swissprot;acc:p50539]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.999\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.357\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
257\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDOST\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kda subunit precursor (ec 2.4.1.119) (oligosaccharyl transferase 48 kda subunit) (ddost 48 kda subunit). [source:swissprot;acc:p39656]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.691\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
179.88\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
258\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MXD4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
max-interacting transcriptional repressor mad4 (max-associated protein 4) (max dimerization protein 4). [source:swissprot;acc:q14582]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
227.999\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.366\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11564\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
259\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAB24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
max dimerization protein 3; likely ortholog of mouse max dimerization protein 3. [source:refseq;acc:nm\_031300]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
204.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11562\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
260\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HS3ST6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
c439a6.1 (novel protein similar to heparan sulfate (glucosamine) 3-o- sulfotransferases) (fragment). [source:sptrembl;acc:q96qi5]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.421\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
196.978\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11394\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
261\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HS3ST3A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl 3-o-sulfotransferase 3a1; heparin-glucosamine 3-o-sulfotransferase. [source:refseq;acc:nm\_006042]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
262\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HS3ST3B1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl 3-o-sulfotransferase 3b1. [source:refseq;acc:nm\_006041]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
263\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HS3ST2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl  3-o-sulfotransferase 2; heparin-glucosamine 3-o-sulfotransferase. [source:refseq;acc:nm\_006043]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
264\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DCPS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mrna decapping enzyme; histidine triad protein member 5; heat shock-like protein 1. [source:refseq;acc:nm\_014026]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
265\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SF3B1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
splicing factor 3b subunit 1 (spliceosome associated protein 155) (sap 155) (sf3b155) (pre-mrna splicing factor sf3b 155 kda subunit). [source:swissprot;acc:o75533]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.217\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.459\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11241\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
266\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIN3A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcriptional co-repressor sin3a; transcriptional regulator, sin3a (yeast). [source:refseq;acc:nm\_015477]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
241.07\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
267.88\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11121\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
267\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DENR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
density-regulated protein (drp) (drp1 protein) (smooth muscle cell associated protein-3) (smap-3). [source:swissprot;acc:o43583]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
268\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 5 (eif-5). [source:swissprot;acc:p55010]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
271.016\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
244.167\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10996\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
269\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PCYT1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase a (ec 2.7.7.15) (phosphorylcholine transferase a) (ctp:phosphocholine cytidylyltransferase a) (ct a) (cct a) (cct-alpha). [source:swissprot;acc:p49585]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
241.373\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
267.352\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.10763\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
270\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FLAD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fad synthetase. [source:refseq;acc:nm\_025207]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
271\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 2 (paps synthethase 2) (papss 2) (sulfurylase kinase 2) (sk2) (sk 2) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o95340]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
272\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LGTN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ligatin (hepatocellular carcinoma-associated antigen 56). [source:swissprot;acc:p41214]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
273\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PAPSS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 1 (paps synthethase 1) (papss 1) (sulfurylase kinase 1) (sk1) (sk 1) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o43252]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
274\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadph-cytochrome p450 reductase (ec 1.6.2.4) (cpr) (p450r). [source:swissprot;acc:p16435]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
275\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PCYT1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase b (ec 2.7.7.15) (phosphorylcholine transferase b) (ctp:phosphocholine cytidylyltransferase b) (ct b) (cct b) (cct-beta). [source:swissprot;acc:q9y5k3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
276\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNORA7A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l32. [source:swissprot;acc:p02433]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
266.969\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10716\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
277\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s29. [source:swissprot;acc:p30054]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.849\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.642\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10665\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
278\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s11. [source:swissprot;acc:p04643]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.399\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.088\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10642\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
279\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBBP7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone acetyltransferase type b subunit 2 (retinoblastoma binding protein p46) (retinoblastoma-binding protein 7) (rbbp-7). [source:swissprot;acc:q16576]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10605\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
280\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
metastasis-associated protein mta1. [source:swissprot;acc:q13330]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.512\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.356\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10578\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
281\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l17 (l23). [source:swissprot;acc:p18621]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.808\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.335\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10557\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
282\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBBP4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chromatin assembly factor 1 subunit c (caf-1 subunit c) (chromatin assembly factor i p48 subunit) (caf-i 48 kda subunit) (caf-ip48) (retinoblastoma binding protein p48) (retinoblastoma-binding protein 4) (rbbp-4) (msi1 protein homolog). [source:swissprot;acc:q09028]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.297\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10553\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
283\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l11. [source:swissprot;acc:p39026]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.828\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10552\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
284\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BCAR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
crk-associated substrate (p130cas) (breast cancer anti-estrogen resistance 1 protein). [source:swissprot;acc:p56945]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.657\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.235\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10541\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
285\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CCT4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
t-complex protein 1, delta subunit (tcp-1-delta) (cct-delta) (stimulator of tar rna binding). [source:swissprot;acc:p50991]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.647\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.242\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10532\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
286\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEDD9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
enhancer of filamentation 1 (hef1) (crk-associated substrate-related protein) (cas-l) (casl) (pp105) (neural precursor cell expressed developmentally down-regulated 9). [source:swissprot;acc:q14511]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.633\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.251\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1052\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
287\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS4Y2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s4, y isoform 2. [source:swissprot;acc:q8td47]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
240.758\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
266.079\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.10517\vspace{3pt}}}\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
288\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s4, x isoform (single copy abundant mrna protein) (scr10). [source:swissprot;acc:p12750]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
266.078\vspace{3pt}}&\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
289\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
hpaii tiny  fragments locus 9c. [source:refseq;acc:nm\_022727]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
272.781\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
246.892\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10486\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
290\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RRM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m2 chain (ec 1.17.4.1) (ribonucleotide reductase small chain). [source:swissprot;acc:p31350]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.969\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.064\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
291\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NFYB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nuclear transcription factor y subunit beta (nf-y protein chain b) (nf-yb) (ccaat-binding transcription factor subunit a) (cbf-a) (caat- box dna binding protein subunit b). [source:swissprot;acc:p25208]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.679\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.037\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
292\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS15A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s15a. [source:swissprot;acc:p39027]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.411\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
266.414\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10357\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
293\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l23 (l17). [source:swissprot;acc:p23131]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.782\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
265.717\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10356\vspace{3pt}}\\\hline
nd{longtable}

    Legend:
    - Rank is the rank after comparing the two networks
    
 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    
 - Hugo is the HGNC identifier if it exists
    
 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    
 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    
 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    
 - Filtered specifies whether we only included the high confidence microarry measurements or not.
    - http://analysis.yellowcouch.org/